DB00092 | Alefacept | approved, investigational, withdrawn | unknown | | Details |
DB00002 | Cetuximab | approved | unknown | binder | Details |
DB00005 | Etanercept | approved, investigational | unknown | ligand | Details |
DB00028 | Human immunoglobulin G | approved, investigational | yes | antagonist | Details |
DB00056 | Gemtuzumab ozogamicin | approved, investigational | unknown | | Details |
DB00075 | Muromonab | approved, investigational | unknown | | Details |
DB00087 | Alemtuzumab | approved, investigational | unknown | binder | Details |
DB00108 | Natalizumab | approved, investigational | unknown | ligand | Details |
DB00110 | Palivizumab | approved, investigational | unknown | | Details |
DB00111 | Daclizumab | investigational, withdrawn | unknown | | Details |
DB11767 | Sarilumab | approved, investigational | unknown | unknown | Details |
DB06607 | Catumaxomab | approved, investigational, withdrawn | yes | agonist | Details |